Xu Guang-lin, Yu Shu-qin, Gong Zhu-nan, Zhang Shuan-quan
Center for Drug Research and Development, College of Life Science, Nanjing Normal University, Nanjing 210097, China.
Zhongguo Zhong Yao Za Zhi. 2005 Mar;30(5):369-72.
To study the effect of crocin on rat experimental hyperlipemia and its mechanisms.
Hyperlipemia model was established by feeding heavy cholesterol for 2 months and the effect of crocin on blood lipid in experimental hyperlipemia rats was observed. Aortic smooth muscle cells were cultured in different culture media and proliferation was measured by MTT assay. Western blotting was used to detect the effect of crocin on phosphorylation of p38 MAPK.
Crocin not only decreased greatly the content of cholesterol, triglyceride and density lipoprotein in blood, but also increased the content of high density lipoprotein. In addition, the proliferation of smooth muscle cells and the activation of p38MAPK were inhibited by Crocin.
Crocin prevents atherosclerosis in hyperlipemia, which may be mediated by the inhibition of both proliferation of smooth muscle cells and activation of p38MAPK.
研究西红花苷对大鼠实验性高脂血症的影响及其作用机制。
通过喂饲高胆固醇饲料2个月建立高脂血症模型,观察西红花苷对实验性高脂血症大鼠血脂的影响。在不同培养基中培养主动脉平滑肌细胞,采用MTT法检测细胞增殖情况。运用蛋白质免疫印迹法检测西红花苷对p38丝裂原活化蛋白激酶(p38 MAPK)磷酸化的影响。
西红花苷不仅能显著降低血液中胆固醇、甘油三酯和低密度脂蛋白的含量,还能提高高密度脂蛋白的含量。此外,西红花苷可抑制平滑肌细胞的增殖以及p38 MAPK的激活。
西红花苷可预防高脂血症中的动脉粥样硬化,其机制可能是通过抑制平滑肌细胞增殖和p38 MAPK激活来介导的。